Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.

Messenheimer DJ, Jensen SM, Afentoulis ME, Wegmann KW, Feng Z, Friedman DJ, Gough MJ, Urba WJ, Fox BA.

Clin Cancer Res. 2017 Oct 15;23(20):6165-6177. doi: 10.1158/1078-0432.CCR-16-2677. Epub 2017 Aug 28.

PMID:
28855348
2.

Correction: Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.

Feng Z, Jensen SM, Messenheimer DJ, Farhad M, Neuberger M, Bifulco CB, Fox BA.

J Immunol. 2017 Feb 15;198(4):1759. doi: 10.4049/jimmunol.1601990. No abstract available.

3.

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.

Young KH, Baird JR, Savage T, Cottam B, Friedman D, Bambina S, Messenheimer DJ, Fox B, Newell P, Bahjat KS, Gough MJ, Crittenden MR.

PLoS One. 2016 Jun 9;11(6):e0157164. doi: 10.1371/journal.pone.0157164. eCollection 2016.

4.

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.

Feng Z, Jensen SM, Messenheimer DJ, Farhad M, Neuberger M, Bifulco CB, Fox BA.

J Immunol. 2016 May 1;196(9):3943-50. doi: 10.4049/jimmunol.1502635. Epub 2016 Mar 18. Erratum in: J Immunol. 2017 Feb 15;198(4):1759.

Supplemental Content

Loading ...
Support Center